Safety and drug quantification of the dapivirine vaginal ring and oral preexposure prophylaxis in breastfeeding motherinfant pairs MTN043 a phase 3B openlabel randomised trial

Simple item page
dc.article.end-page190en
dc.article.start-page180en
dc.citation.doi10.1016/S2352-3018(24)00306-0en
dc.contributor.authorLisa M Noguchien
dc.contributor.authorMaxensia Oworen
dc.contributor.authorNyaradzo M Mgodien
dc.contributor.authorBrenda Gati Mirembeen
dc.contributor.authorElizea Horneen
dc.contributor.authorE et alen
dc.date.accessioned2026-03-26T13:39:20Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2352-3018en
dc.identifier.urihttps://hdl.handle.net/10539/48734
dc.journal.titleSafety and drug quantification of the dapivirine vaginal ring and oral preexposure prophylaxis in breastfeeding motherinfant pairs MTN043 a phase 3B openlabel randomised trialen
dc.journal.volume12en
dc.titleSafety and drug quantification of the dapivirine vaginal ring and oral preexposure prophylaxis in breastfeeding motherinfant pairs MTN043 a phase 3B openlabel randomised trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
838.06 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)